Timely Antiviral Administration During an Influenza Pandemic: Key Components.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30192657.
- Also identified by DOI 10.2105/AJPH.2018.304609 and PMC identifier 6129661.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prompt treatment of ill persons with influenza antivirals will be an important part of a future pandemic influenza response. This essay reviews key lessons learned from the 2009 H1N1 pandemic and the changing landscape of antiviral drug availability, and identifies and describes the multiple components needed to ensure the timely administration of antiviral drugs during a future pandemic. Fortunately, many of these planning efforts can take place before a pandemic strikes to improve outcomes during a future public health emergency.
Medical subject headings
- Antiviral Agents
- Disaster Planning
- Influenza, Human
- Medical Countermeasures
- Pandemics